Navigation Links
BioInformatics, LLC New Report - Exploring the Epigenetics Market: Opportunities for Product Placement and Innovations

ARLINGTON, Va., June 18 /PRNewswire/ -- BioInformatics, LLC announces the pending release of its newest report, Exploring the Epigenetics Market: Opportunities for Product Placement and Innovations. Designed to provide guidance for life science suppliers selling products that support epigenetic research involving chromosome immunoprecipitation (chIP), this report will help suppliers optimize product offerings and strengthen market position. For this report, BioInformatics, LLC (, the premier research and advisory firm serving the life science market, fielded a detailed 56-question survey to scientists worldwide about their current--and planned--areas of study in epigenetics research, usage of related products and preferred suppliers.

The report is scheduled to release in mid-July, and is available at pre-release pricing until July 15, 2009.

Advances enabling faster and cheaper mapping of epigenetic modifications have accelerated discoveries in the field. Since 2007, the National Institutes of Health has supported these efforts with the creation and funding of the Epigenomics Roadmap Initiative, which promotes the discovery of epigenetic markers and the development of new epigenetics-based tools. Exploring the Epigenetics Market: Opportunities for Product Placement and Innovations reviews progress in both of these areas and highlights opportunities for suppliers interested in designing and manufacturing new technologies to support epigenetics researchers. In this study, scientists elaborate on processes and techniques they use to do epigenetics research, problems with protocols and antibodies, changes expected in the time/effort devoted to epigenetics research over the next couple of years and the estimated change in spending on chIP consumables through 2011.

Scientists also provide opinions about suppliers of chIP and non-chIP grade antibodies, and indicate how these products are used, satisfaction with suppliers and desired improvements with each. The following suppliers were provided as choices in the survey:

Abcam (LSE: ABC.L)


Active Motif

Affinity Bioreagents (Thermo Fisher Scientific (NYSE: TMO))

Alexis Biochemicals (Enzo Life Sciences) (NYSE: ENZ)

Aviva Systems Biology

BD Biosciences Immunocytometry Systems

BD Biosciences Pharmingen (NYSE: BDX)

Beckman Coulter (NYSE: BEC)

Bethyl Laboratories

BioChemika (Sigma-Aldrich) (NasdaqGS: SIAL)

Biogenesis (MorphoSys)


BIOMOL (Enzo Life Sciences)

BioSource (Life Technologies) (NasdaqGS: LIFE)

Calbiochem (EMD) (NYSE: EMD)

Caltag (life Technologies)

Cell Signaling Technology

Chemicon International (Millipore) (NYSE: MIL)

Covance (NYSE: CVD)



Dynal Biotech (Life Technologies)


Endogen (Thermo Fisher Scientific)

GE Healthcare (Amersham) (NYSE: GE)


Invitrogen (Life Technologies) (Nasdaq: LIFE)

Jackson ImmunoResearch Laboratories


LabVision Corporation (Thermo Fisher Scientific)

Miltenyi Biotech

Millipore (NYSE: MIL)

Molecular Probes (Life Technologies)

NeoMarkers (Thermo Fisher Scientific)

Novus Biologicals

Pierce (Thermo Fisher Scientific)


Quantum Dot (Life Technologies (Invitrogen))

R&D Systems (division of TECHNE Corp., Nasdaq: TECH)

Roche Applied Science

Rockland Immunochemicals


Santa Cruz Biotechnology

Serotec (MorphoSys)

Sigma-Aldrich (Nasdaq: SIAL)

Upstate (Millipore)

Vector Laboratories

Zymed (Life Technologies (Invitrogen))

"While the majority of the survey respondents are involved in gene regulation studies, changes to the epigenetic state play a central role in many diseases. Cancer is one of the best-studied examples, but many other pathologies, including diabetes, neurological disorders, and aging may have epigenetic contributions," states Tamara Zemlo, Ph.D., MPH, Vice President of Advisory Services. Dr. Zemlo has been the senior analyst on over 80 syndicated market research reports, and presented findings from Exploring the Epigenetics Market: Opportunities for Product Placement and Innovations at the 2009 Consumer Genetics Show at the Hynes Convention Center in Boston, MA on June 9.

To learn more about this report, a complimentary Executive Summary is available at


BioInformatics, LLC is the premier research and advisory firm serving the life science industry. By leveraging our professional social network of more than 43,000 biomedical researchers, we have supported more than 300 companies and provided insights that lead to better business decisions. Our assignments include assessing the size and attractiveness of markets, optimizing product configurations and pricing, validating corporate acquisitions, measuring customer loyalty, and evaluating brand strength and positioning.

    For more information contact:

    Mary Follin
    Manager, Marketing/Sales
    BioInformatics, LLC
    2111 Wilson Blvd., Suite 250
    Arlington, VA  22201
    703.778.3080 x13 (phone)

SOURCE BioInformatics, LLC
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. BioInformatics, LLC New Report - Capitalizing on New Opportunities for Stem Cell Products
2. BioInformatics, LLC, A Recognized Sponsor of First Annual Consumer Genetics Show in Boston, June 9-11, 2009
3. Childrens Hospital of Philadelphia Earns Highest Combined US News Score in 10 Specialties Ranked by U.S. News & World Report
4. Childrens Named Among the Nations Top 10 Pediatric Hospitals by U.S.News & World Report
5. Stroke survivors report loss of sexual desire, blurred gender roles, anger and fatigue
6. Imagenetix, Inc. Reports Year End Results
7. New Swine Flu Strain Found in Brazil: Report
8. Somanetics Reports Second Quarter Results and Extension of Exclusive Distribution Agreement With Covidien
9. Report: Asbestos Litigation Disaster for Investors Could Be Repeated With Nanotechnology Unless SEC and FASB Close Eight Major Loopholes Now Preventing Honest Disclosures
10. Reportable Food Registry Draft Guidance Published for Comment by FDA
11. New Poll Finds Most Americans Support Including Treatment for Drug and Alcohol Addiction in National Health Care Reform; All Demographics Report Personal Experience With the Disease
Post Your Comments:
(Date:6/25/2016)... Lewisville, TX (PRWEB) , ... June 25, 2016 , ... ... in the United States, named Dr. Sesan Ogunleye, as the Medical Director of its ... be the facility Medical Director of our new Mesquite location,” said Dr. James M. ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... Conventional wisdom ... of success. In terms of the latter, setting the bar too high can result ... more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... ... 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was out of ... verbally and physically. , “When something upset him, he couldn’t control his emotions,” remembers Marcy. ... throw rocks at my other children and say he was going to kill them. ...
(Date:6/24/2016)... ... , ... Comfort Keepers® of San Diego, CA is excited to announce they ... to drive cancer patients to and from their cancer treatments. Comfort Keepers provides ... life and ongoing independence. Getting to and from medical treatments is one of ...
(Date:6/24/2016)... ... 24, 2016 , ... The Haute Beauty Network, affiliated with ... as a prominent plastic surgeon and the network’s newest partner. , Dr. ... handsome men, look naturally attractive. Plastic surgery should be invisible.” He stands by ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... OAKLAND, N.J. , June 24, 2016 /PRNewswire/ ... in the design, development and manufacturing of collagen ... and regeneration announced today that Bill Messer ... Sales and Marketing to further leverage the growing ... surgery medical devices. Bill joins the ...
(Date:6/24/2016)... Va. , June 24, 2016 The ... set of recommendations that would allow biopharmaceutical ... (HCEI) with entities that make formulary and coverage decisions, ... the "value" of new medicines. The recommendations ... does not appear on the drug label, a prohibition ...
(Date:6/24/2016)... 2016   Pulmatrix, Inc ., (NASDAQ: ... drugs, announced today that it was added to the ... its comprehensive set of U.S. and global equity indexes ... important milestone for Pulmatrix," said Chief Executive Officer ... our progress in developing drugs for crucial unmet medical ...
Breaking Medicine Technology: